Application and Development of Computational Approaches to Optimize Treatment of Malignancies using Routine Clinical Data

Autor: Pérez-Solans, B. (Belén), Troconiz, I.F. (Iñaki F.), Santisteban, M. (Marta)

Publikováno v: Dadun: Depósito Académico Digital de la Universidad de Navarra
Universidad de Navarra
Dadun. Depósito Académico Digital de la Universidad de Navarra
Consejo Superior de Investigaciones Científicas (CSIC)

The use of personalised medicine in oncology is gaining recognition as a way of enabling individualised tailored-treatment based on patient’s genetic signatures and clinical characteristics. The characterisation of drug exposure and the way it affe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f6aa2d53e1a0c21aecadb1f883ce7802
https://hdl.handle.net/10171/61118

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis.

Autor: Ali AM; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco , San Francisco, California, USA.; Department of Interventions and Clinical Trials, Bagamoyo Research and Training Center, Ifakara Health Institute , Bagamoyo, Tanzania., P Solans B; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco , San Francisco, California, USA., Hesseling AC; Department of Paediatrics and Child Health, Desmond Tutu TB Centre, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town, South Africa., Winckler J; Department of Paediatrics and Child Health, Desmond Tutu TB Centre, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town, South Africa., Schaaf HS; Department of Paediatrics and Child Health, Desmond Tutu TB Centre, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town, South Africa., Draper HR; Department of Paediatrics and Child Health, Desmond Tutu TB Centre, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town, South Africa., van der Laan L; Department of Paediatrics and Child Health, Desmond Tutu TB Centre, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town, South Africa., Hughes J; Department of Paediatrics and Child Health, Desmond Tutu TB Centre, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town, South Africa., Fourie B; Department of Paediatrics and Child Health, Desmond Tutu TB Centre, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town, South Africa., Nielsen J; Department of Pediatrics, New York University School of Medicine , New York, New York, USA., Wiesner L; Department of Medicine, Division of Clinical Pharmacology, University of Cape Town , Cape Town, South Africa., Garcia-Prats AJ; Department of Paediatrics and Child Health, Desmond Tutu TB Centre, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town, South Africa.; Department of Pediatrics, University of Wisconsin-Madison, School of Medicine and Public Health , Madison, Wisconsin, USA., Savic RM; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco , San Francisco, California, USA.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Jan 10; Vol. 68 (1), pp. e0079423. Date of Electronic Publication: 2023 Dec 19.